Wealthfront Advisers
EMN icon

Wealthfront Advisers’s Eastman Chemical EMN Stock Holding History

Wealthfront Advisers’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
4,911
-142
-3% -$10.4K ﹤0.01% 961
2026
Q1 		$386K Sell
5,053
-103
-2% -$7.42K ﹤0.01% 890
2025
Q4 		$329K Sell
5,156
-2,039
-28% -$126K ﹤0.01% 904
2025
Q3 		$454K Sell
7,195
-616
-8% -$43K ﹤0.01% 833
2025
Q2 		$583K Sell
7,811
-12,011
-61% -$944K ﹤0.01% 772
2025
Q1 		$1.75M Sell
19,822
-1,756
-8% -$166K ﹤0.01% 568
2024
Q4 		$1.97M Sell
21,578
-1,161
-5% -$119K 0.01% 527
2024
Q3 		$2.55M Sell
22,739
-647
-3% -$64.7K 0.01% 447
2024
Q2 		$2.29M Sell
23,386
-961
-4% -$95.4K 0.01% 455
2024
Q1 		$2.44M Buy
24,347
+30
+0.1% +$2.64K 0.01% 440
2023
Q4 		$2.18M Buy
24,317
+15,636
+180% +$1.25M 0.01% 444
2023
Q3 		$666K Sell
8,681
-73
-0.8% -$6.06K ﹤0.01% 637
2023
Q2 		$733K Sell
8,754
-289
-3% -$23.5K ﹤0.01% 612
2023
Q1 		$763K Sell
9,043
-220
-2% -$18.9K ﹤0.01% 576
2022
Q4 		$754K Buy
9,263
+333
+4% +$26.8K ﹤0.01% 559
2022
Q3 		$634K Sell
8,930
-449
-5% -$40.4K ﹤0.01% 555
2022
Q2 		$842K Buy
9,379
+166
+2% +$17.2K ﹤0.01% 512
2022
Q1 		$1.03M Sell
9,213
-887
-9% -$104K ﹤0.01% 520
2021
Q4 		$1.22M Buy
10,100
+295
+3% +$32.8K 0.01% 475
2021
Q3 		$988K Sell
9,805
-2,813
-22% -$310K ﹤0.01% 473
2021
Q2 		$1.47M Buy
12,618
+2,710
+27% +$325K 0.01% 362
2021
Q1 		$1.09M Buy
9,908
+1
+0% +$109 0.01% 373
2020
Q4 		$993K Sell
9,907
-50
-0.5% -$4.64K 0.01% 360
2020
Q3 		$778K Sell
9,957
-143
-1% -$10.8K 0.01% 370
2020
Q2 		$703K Sell
10,100
-14,166
-58% -$893K 0.01% 375
2020
Q1 		$1.13M Buy
24,266
+21,704
+847% +$1.39M 0.01% 258
2019
Q4 		$203K Buy
+2,562
New +$197K ﹤0.01% 490
2019
Q3 		– Sell
-2,701
Closed -$210K – 474
2019
Q2 		$210K Buy
+2,701
New +$205K ﹤0.01% 478

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wealthfront Advisers's EMN Position: Q2 2026 in Review

Wealthfront Advisers reduced its Eastman Chemical (EMN) stake by 2.8% in Q2 2026, selling an estimated $10.4K and leaving 4,911 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Wealthfront Advisers first reported a position in EMN in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.55M in Q3 2024. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Wealthfront Advisers held 4,911 shares of Eastman Chemical worth $329K as of Q2 2026.
  • Wealthfront Advisers sold 142 Eastman Chemical shares in Q2 2026, an estimated $10.4K.
  • Eastman Chemical made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #961 holding.
  • Wealthfront Advisers first reported a position in Eastman Chemical in Q2 2019 and has held it in 28 quarters since.
  • Wealthfront Advisers's Eastman Chemical position peaked at $2.55M in Q3 2024.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.